PHARMA SOLACE LIMITED, Manchester, المملكة المتحدة

المساهمون

الاسم	الحصة	التصويت	منذ

المستفيد الحقيقي النهائي

الاسم	الملكية	البلد	منذ

البيانات المالية

الأرقام الرئيسية من إيداعات الحسابات السنوية.

تحويل إلى

2012

الربح / (الخسارة): £-14.0K

الأرقام الرئيسية

الربح / (الخسارة)

2010—

2012£‎-14,032

2013£46,217

2014£4,287

2015£2,595

2016£5,651

إجمالي الأصول

2010£1

2012£‎-14,031

2013£46,218

2014£4,288

2015£2,596

2016£5,652

Current Assets

2010—

2012£91,686

2013£133,285

2014£137,243

2015£113,263

2016£113,502

Net Current Assets Liabilities

2010—

2012£‎-54,410

2013£1,347

2014£‎-33,511

2015£‎-30,276

2016£‎-21,650

Total Assets Less Current Liabilities

2010—

2012£‎-14,031

2013£46,218

2014£8,738

2015£5,933

2016£8,989

Debtors

2010—

2012£29,060

2013£98,590

2014£119,922

2015£79,053

2016£81,224

Number Shares Allotted

2010—

2012100

2013100

2014100

2015100

2016100

Par Value Share

2010—

2012£0

2013£0

2014£0

2015£0

2016£0

Called Up Share Capital

2010—

2012£1

2013£1

2014£1

2015£1

2016£1

Cash Bank In Hand

2010£1

2012£62,626

2013£12,695

2014£5,321

2015£20,210

2016£18,278

Creditors Due Within One Year

2010—

2012£146,096

2013£131,938

2014£170,754

2015£143,539

2016£135,152

Fixed Assets

2010—

2012—

2013—

2014£42,249

2015£36,209

2016£30,639

Net Assets Liabilities Including Pension Asset Liability

2010£1

2012—

2013£46,218

2014£4,288

2015£2,596

2016£5,652

Profit Loss Account Reserve

2010—

2012£‎-14,032

2013£46,217

2014£4,287

2015£2,595

2016£5,651

Provisions For Liabilities Charges

2010—

2012—

2013£0

2014£4,450

2015£3,337

2016£3,337

Share Capital Allotted Called Up Paid

2010—

2012£1

2013£1

2014—

2015—

2016—

Shareholder Funds

2010£1

2012£‎-14,031

2013£46,218

2014£4,288

2015£2,596

2016£5,652

Stocks Inventory

2010—

2012£0

2013£22,000

2014£12,000

2015£14,000

2016£14,000

Tangible Fixed Assets

2010—

2012£40,379

2013£44,871

2014£42,249

2015£36,209

2016£30,639

Tangible Fixed Assets Additions

2010—

2012£12,797

2013£5,124

2014—

2015—

2016—

Tangible Fixed Assets Cost Or Valuation

2010—

2012£58,449

2013£63,573

2014—

2015—

2016—

Tangible Fixed Assets Depreciation

2010—

2012£13,578

2013£21,323

2014—

2015—

2016—

Tangible Fixed Assets Depreciation Charged In Period

2010—

2012£8,305

2013£7,745

2014—

2015—

2016—

Value Shares Allotted

2010—

2012—

2013—

2014£1

2015£1

2016£1

متري	2010	2012	2013	2014	2015	2016
الربح / (الخسارة)	—	£‎-14,032	£46,217	£4,287	£2,595	£5,651
إجمالي الأصول	£1	£‎-14,031	£46,218	£4,288	£2,596	£5,652
Current Assets	—	£91,686	£133,285	£137,243	£113,263	£113,502
Net Current Assets Liabilities	—	£‎-54,410	£1,347	£‎-33,511	£‎-30,276	£‎-21,650
Total Assets Less Current Liabilities	—	£‎-14,031	£46,218	£8,738	£5,933	£8,989
Debtors	—	£29,060	£98,590	£119,922	£79,053	£81,224
Number Shares Allotted	—	100	100	100	100	100
Par Value Share	—	£0	£0	£0	£0	£0
Called Up Share Capital	—	£1	£1	£1	£1	£1
Cash Bank In Hand	£1	£62,626	£12,695	£5,321	£20,210	£18,278
Creditors Due Within One Year	—	£146,096	£131,938	£170,754	£143,539	£135,152
Fixed Assets	—	—	—	£42,249	£36,209	£30,639
Net Assets Liabilities Including Pension Asset Liability	£1	—	£46,218	£4,288	£2,596	£5,652
Profit Loss Account Reserve	—	£‎-14,032	£46,217	£4,287	£2,595	£5,651
Provisions For Liabilities Charges	—	—	£0	£4,450	£3,337	£3,337
Share Capital Allotted Called Up Paid	—	£1	£1	—	—	—
Shareholder Funds	£1	£‎-14,031	£46,218	£4,288	£2,596	£5,652
Stocks Inventory	—	£0	£22,000	£12,000	£14,000	£14,000
Tangible Fixed Assets	—	£40,379	£44,871	£42,249	£36,209	£30,639
Tangible Fixed Assets Additions	—	£12,797	£5,124	—	—	—
Tangible Fixed Assets Cost Or Valuation	—	£58,449	£63,573	—	—	—
Tangible Fixed Assets Depreciation	—	£13,578	£21,323	—	—	—
Tangible Fixed Assets Depreciation Charged In Period	—	£8,305	£7,745	—	—	—
Value Shares Allotted	—	—	—	£1	£1	£1

PHARMA SOLACE LIMITED

الملخص

القانونية والوضع القانوني

الجدول الزمني (27 الأحداث)

الحسابات السنوية المودعة

الحسابات السنوية المودعة

استقالة Ocs Corporate Secretaries Limited (شخص)

الشبكة

الملكية والإدارة

Persons with significant control

Officers & directors

الجدول الزمني للملكية (1 التغييرات)

تعيين Usman Aslam (شخص)

المساهمون

المستفيد الحقيقي النهائي

الجغرافيا

البيانات المالية

الأرقام الرئيسية

المستندات

تقرير الشركة PHARMA SOLACE LIMITED

Final Gazette dissolved via voluntary strike-off

Voluntary strike-off action has been suspended

First Gazette notice for voluntary strike-off

Strike off from register

Total exemption small company accounts made up to 31 October 2016

Registration of particulars of charge

Previous accounting period extended from 31 August 2016 to 31 October 2016

Appointment of director

Termination of director appointment

Companexia Document AI

تصفح المزيد من الشركات والأشخاص

الصحة المالية

النمو

الكفاءة والعائد

رأس المال العامل والسيولة